<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pak J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Pak J Med Sci</journal-id><journal-id journal-id-type="publisher-id">PJMS</journal-id><journal-title-group><journal-title>Pakistan Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1682-024X</issn><issn pub-type="epub">1681-715X</issn><publisher><publisher-name>Professional Medical Publications</publisher-name><publisher-loc>Pakistan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26648989</article-id><article-id pub-id-type="pmc">4641258</article-id><article-id pub-id-type="publisher-id">PJMS-31-1073</article-id><article-id pub-id-type="doi">10.12669/pjms.315.7996</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of intravenously infused lidocaine on analgesia and gastrointestinal function of patients receiving laparoscopic common bile duct exploration</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Wei-Lan</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Wei Yang, Department of Anesthesiology, Central Hospital of Xinxiang, Xinxiang 453000, He&#x02019;nan Province, China</aff><aff id="aff2"><label>2</label>Wei-Lan Hu, Department of Anesthesiology, Central Hospital of Xinxiang, Xinxiang 453000, He&#x02019;nan Province, China</aff><author-notes><corresp id="cor1">
Correspondence: Wei Yang, Department of Anesthesiology, Central Hospital of Xinxiang, Xinxiang 453000, He&#x02019;nan Province, China. E-mail: <email xlink:href="yangweichx@163.com">yangweichx@163.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2015</year></pub-date><volume>31</volume><issue>5</issue><fpage>1073</fpage><lpage>1077</lpage><history><date date-type="received"><day>20</day><month>4</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Pakistan Journal of Medical Sciences</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective:</title><p>To evaluate the effects of intravenously infused lidocaine on analgesia and gastrointestinal function of patients receiving laparoscopic common bile duct exploration.</p></sec><sec id="st2"><title>Methods:</title><p>Seventy-eight patients with cholelithiasis were randomly divided into a treatment group and a control group (n=39) that all had laparoscopic common bile duct exploration. The treatment group was intravenously infused with 1.5 mg/kg lidocaine by using a venous pump under anesthesia induction at the speed of 2 mg&#x000b7;kg<sup>-1</sup> &#x000b7;h<sup>-1</sup> until the end of surgery, while the control group was given normal saline with the same volume.</p></sec><sec id="st3"><title>Results:</title><p>All patients successfully completed the surgery, with similar surgical time, incision length and intraoperative blood loss. The required lidocaine concentrations of the treatment group were 2.64&#x000b1;1.23 &#x003bc;g/ml, 1.14&#x000b1;0.4 &#x003bc;g/ml and 0.93&#x000b1;0.32 &#x003bc;g/ml respectively 2 hour, 12 hour and 48 hour after surgery. Pain score of the treatment group, which was significantly lower than that of the control group at the postoperative 2 hour (P&#x0003c;0.05), was similar to those of the control group at the postoperative 12 hour and 48 hour. With extended time, the pain score significantly decreased (P&#x0003c;0.05). The treatment group had significantly shorter first anal exhaust time and first defecation time than those of the control group (P&#x0003c;0.05). Adverse reactions, such as nausea and vomiting, dizziness, headache, subcutaneous emphysema and fat liquefaction of incision, occurred similarly in the two groups, which were alleviated by symptomatic treatment.</p></sec><sec id="st4"><title>Conclusion:</title><p>Laparoscopic common bile duct exploration is a promising minimally invasive surgery for patients with cholelithiasis, during which intravenously infused lidocaine can rapidly recover the gastrointestinal function and exert short-term analgesic effects, with mild adverse reactions also.</p></sec></abstract><kwd-group><title>KEY WORDS</title><kwd>Adverse reaction</kwd><kwd>Analgesia</kwd><kwd>Gastrointestinal function</kwd><kwd>Lidocaine</kwd><kwd>Laparoscopic common bile duct exploration</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Cholelithiasis, as a common and frequently-occurring disease in general surgery departments, accounts for approximately 12.0% of patients hospitalized in the same period.<xref rid="ref1" ref-type="bibr">1</xref> Traditionally, it is treated by laparotomy, with satisfactory outcomes also.<xref rid="ref2" ref-type="bibr">2</xref> With development of medical devices and surgical techniques, minimally invasive surgeries, especially laparoscopic common bile duct exploration, have been given first priority recently.<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref4" ref-type="bibr">4</xref> However, this surgery should be assisted by using postoperative analgesic protocols. Stimuli such as surgical traumas and traction directly affect the prognosis by exposing the intestinal canal and leading to contraction and relaxation dysfunction of intestinal muscles. Shortening the postoperative anal exhaust time to resume eating as early as possible plays an important role in promoting the recovery of gastrointestinal function.<xref rid="ref5" ref-type="bibr">5</xref></p><p>Proper analgesic protocols not only effectively inhibit the rising of catecholamine concentration, but also benefit the recovery of gastrointestinal function. However, traditional epidural analgesia affects early postoperative activities, often accompanied by adverse reactions such as nausea, vomiting and urinary retention.<xref rid="ref6" ref-type="bibr">6</xref> Once being applied to general anesthesia, lidocaine can prevent fentanyl-induced cough reflex, and resist convulsion and arrhythmia. Besides, it is capable of cerebral protection, intracranial pressure reduction, and inhibition of pathogenic bacteria and isolated fungi.<xref rid="ref7" ref-type="bibr">7</xref> Nonetheless, lidocaine has both exciting and inhibitory effects on the central nervous system. The pain threshold increases at low plasma concentration which, if exceeds 5 &#x003bc;g/ml, may result in convulsion.<xref rid="ref8" ref-type="bibr">8</xref></p><p>In this study, we evaluated the effects of intravenously infused lidocaine on analgesia and gastrointestinal function of patients receiving laparoscopic common bile duct exploration, aiming to find a safe, effective way for using this analgesic agent.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><sec id="sec2-1"><title>Subjects</title><p>Seventy-eight patients with cholelithiasis hospitalized from May 2011 to December 2014 were selected. This study has been approved by the ethics committee of our hospital, and written consent was obtained from all patients.</p></sec><sec id="sec2-2"><title>Inclusion criteria</title><p>18-65 years old; ASA I-II; hospitalized patients who were about to receive laparoscopic common bile duct exploration; diagnosed as cholelithiasis by abdominal ultrasonic B-scanning, CT and/or MRCP; with history of upper right abdomen pain.</p></sec><sec id="sec2-3"><title>Exclusion criteria</title><p>With preoperative block; with history of peptic ulcer or renal failure, hepatic insufficiency, or mental disorder; administration of steroids or long-term use of opioids; with difficulty in language communication; allergic to lidocaine. The patients were randomly divided into a treatment group and a control group (n=39), with similar age, gender ratio, disease type disease course and complicated diseases (P&#x0003e;0.05) (<xref ref-type="table" rid="T1">Table-I</xref>).</p><table-wrap id="T1" position="float"><label>Table-I</label><caption><p>Baseline clinical data (x&#x000b1;s)</p></caption><table frame="hsides" rules="rows" width="100%"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Index</th><th align="center" valign="top" rowspan="1" colspan="1">Treatment group (n=39)</th><th align="center" valign="top" rowspan="1" colspan="1">Control group (n=39)</th><th align="center" valign="top" rowspan="1" colspan="1">t or &#x003c7;<sup>2</sup> or Uc</th><th align="center" valign="top" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (male/female)</td><td align="center" valign="top" rowspan="1" colspan="1">20/19</td><td align="center" valign="top" rowspan="1" colspan="1">21/18</td><td align="center" valign="top" rowspan="1" colspan="1">0.089</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (year)</td><td align="center" valign="top" rowspan="1" colspan="1">54.93&#x000b1;5.39</td><td align="center" valign="top" rowspan="1" colspan="1">54.76&#x000b1;6.23</td><td align="center" valign="top" rowspan="1" colspan="1">0.219</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">20.10&#x000b1;5.30</td><td align="center" valign="top" rowspan="1" colspan="1">20.87&#x000b1;4.10</td><td align="center" valign="top" rowspan="1" colspan="1">0.349</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease type (gallstone complicated with choledocholithiasis/chronic cholecystitis complicated with choledocholithiasis)</td><td align="center" valign="top" rowspan="1" colspan="1">22/28/10/10</td><td align="center" valign="top" rowspan="1" colspan="1">23/27/12/8</td><td align="center" valign="top" rowspan="1" colspan="1">0.109</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease course (year)</td><td align="center" valign="top" rowspan="1" colspan="1">1.24&#x000b1;0.45</td><td align="center" valign="top" rowspan="1" colspan="1">1.23&#x000b1;0.29</td><td align="center" valign="top" rowspan="1" colspan="1">0.019</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Complicated disease (diabetes/hypertension/coronary artery disease/bronchitis/others)</td><td align="center" valign="top" rowspan="1" colspan="1">2.45&#x000b1;0.67</td><td align="center" valign="top" rowspan="1" colspan="1">2.41&#x000b1;0.54</td><td align="center" valign="top" rowspan="1" colspan="1">0.133</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr></tbody></table></table-wrap></sec><sec id="sec2-4"><title>Analgesic methods for surgery and anesthesia</title><p>All patients were subjected to laparoscopic common bile duct exploration. After epidural anesthesia or general anesthesia, they were placed in the supine position, and the surgical field was sterilized with drapes. CO<sub>2</sub> pneumoperitoneum was established by using a four-hole method. The cystic duct and cystic artery were isolated, but the former was temporarily not severed. Anterior wall of the common bile duct below the confluence of the cystic duct, which was subjected to two stitches with 3-0# silk suture, was cut open with an electrocautery. The incision was enlarged by scissoring upwards and downwards. Then a choledochoscope was inserted into the common bile duct for exploration after continuous rinsing. Afterwards, a helical gallstone-capturing basket was led in through the choledochoscope to collect gallstones. After the bile duct was rinsed again, T tube was fixed by suturing under the laparoscope, indwelling abdominal drains. Finally, the pneumoperitoneum was destroyed, and the incision was sutured.</p><p>No postoperative medications were given during anesthesia. Atropine (0.25 mg) was intravenously administered on the back of the left hand before anesthesia induction during which 50 &#x003bc;g fentanyl and 2 mg/kg promethazine were intravenously given. Isoflurane (1-2%) and nitrous oxide (66%) were used for intraoperative maintenance. Lidocaine (Shanghai Harvest Pharmaceutical Co., Ltd., batch No. 090713) was intravenously infused during anesthesia induction (1.5 mg/kg) and continuously given at the speed of 0.5 mg&#x000b7;kg<sup>-1</sup> &#x000b7;h<sup>-1</sup> by using a venous pump until the end of surgery. The control group was given normal saline at the same volume. Patient-controlled analgesia (PCA) using morphine at the dose of 1 mg with the lockout time of 7 minutes was utilized for postoperative pain relief. For the PCA pump, 60 mg morphine was mixed with 8 mg ondansetron and diluted to 60 ml with normal saline.</p><p>Perioperative blood pressure, electrocardiogram, pulse oxygen saturation, end-tidal carbon dioxide concentration, tidal volume, respiratory rate and airway resistance were monitored and symptomatically treated.</p></sec><sec id="sec2-5"><title>Observation indices</title><p>Perioperative indices: Surgical time, incision length, intraoperative blood loss and postoperative hospitalization stay length were observed and recorded.</p></sec><sec id="sec2-6"><title>Gastrointestinal function indices</title><p>The first postoperative anal exhaust time and first defecation time were observed and recorded.</p></sec><sec id="sec2-7"><title>Pain status</title><p>Visual analogue scale was employed for both groups 2 huor, 12 hour and 48 hour after surgery. 0: Pain free; 1-3 points: mild pain; 4-6 points: moderate pain; 7-9 points: severe pain; 10 points: insufferable pain. Meanwhile, the plasma concentrations of lidocaine in the venous blood of the treatment group were measured at the same time points.</p></sec><sec id="sec2-8"><title>Adverse reactions</title><p>Postoperative adverse reactions such as nausea and vomiting, dizziness, headache, subcutaneous emphysema and fat liquefaction of incision were observed and recorded.</p></sec><sec id="sec2-9"><title>Statistical analysis</title><p>All data were analyzed by SPSS 14.0. The categorical data were expressed as mean &#x000b1; standard deviation and compared by the t test. Inter-group comparisons were performed with analysis of variance. The numerical data were compared by using Chi-square test, and the ordinal data were compared with the Wilcoxon rank-sum test. P&#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><sec id="sec2-10"><title>Perioperative indices</title><p>All patients successfully completed the surgery, with similar surgical time, incision length and intraoperative blood loss. However, the postoperative hospitalization stay length of the treatment group was significantly shorter than that of the control group (P&#x0003c;0.05) (<xref ref-type="table" rid="T2">Table-II</xref>).</p><table-wrap id="T2" position="float"><label>Table-II</label><caption><p>Perioperative indices (x&#x000b1;s).</p></caption><table frame="hsides" rules="rows" width="100%"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Group</th><th align="center" valign="top" rowspan="1" colspan="1">Case No. (n)</th><th align="center" valign="top" rowspan="1" colspan="1">Surgical time (min)</th><th align="center" valign="top" rowspan="1" colspan="1">Incision length (cm)</th><th align="center" valign="top" rowspan="1" colspan="1">Intraoperative blood loss (ml)</th><th align="center" valign="top" rowspan="1" colspan="1">Postoperative hospitalization stay length (d)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Treatment group</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">185.92&#x000b1;33.29</td><td align="center" rowspan="1" colspan="1">4.39&#x000b1;1.82</td><td align="center" rowspan="1" colspan="1">67.29&#x000b1;12.76</td><td align="center" rowspan="1" colspan="1">6.98&#x000b1;2.19</td></tr><tr><td align="left" rowspan="1" colspan="1">Control group</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">183.55&#x000b1;29.89</td><td align="center" rowspan="1" colspan="1">4.45&#x000b1;1.72</td><td align="center" rowspan="1" colspan="1">68.32&#x000b1;11.37</td><td align="center" rowspan="1" colspan="1">13.76&#x000b1;2.45</td></tr><tr><td align="left" rowspan="1" colspan="1">t</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.173</td><td align="center" rowspan="1" colspan="1">0.287</td><td align="center" rowspan="1" colspan="1">0.429</td><td align="center" rowspan="1" colspan="1">9.112</td></tr><tr><td align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x0003e;0.05</td><td align="center" rowspan="1" colspan="1">&#x0003e;0.05</td><td align="center" rowspan="1" colspan="1">&#x0003e;0.05</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr></tbody></table></table-wrap></sec><sec id="sec2-11"><title>Indices for gastrointestinal function recovery</title><p>The treatment group had significantly shorter first postoperative anal exhaust time and first defecation time than those of the control group (P&#x0003c;0.05) (<xref ref-type="table" rid="T3">Table-III</xref>).</p><table-wrap id="T3" position="float"><label>Table-III</label><caption><p>Indices for gastrointestinal function recovery (h, x&#x000b1;s).</p></caption><table frame="hsides" rules="rows" width="100%"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Group</th><th align="center" valign="top" rowspan="1" colspan="1">Case No. (n)</th><th align="center" valign="top" rowspan="1" colspan="1">First anal exhaust time</th><th align="center" valign="top" rowspan="1" colspan="1">First defecation time</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Treatment group</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">65.39&#x000b1;13.29</td><td align="center" rowspan="1" colspan="1">80.18&#x000b1;16.43</td></tr><tr><td align="left" rowspan="1" colspan="1">Control group</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">75.20&#x000b1;14.22</td><td align="center" rowspan="1" colspan="1">91.87&#x000b1;15.00</td></tr><tr><td align="left" rowspan="1" colspan="1">t</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">10.983</td><td align="center" rowspan="1" colspan="1">11.283</td></tr><tr><td align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr></tbody></table></table-wrap></sec><sec id="sec2-12"><title>Pain scores</title><p>Pain score of the treatment group, which was significantly lower than that of the control group at the postoperative 2 hour (P&#x0003c;0.05), was similar to those of the control group at the postoperative 12 hour and 48 hour. With prolonged time, the score significantly decreased (P&#x0003c;0.05) (<xref ref-type="table" rid="T4">Table-IV</xref>).</p><table-wrap id="T4" position="float"><label>Table-IV</label><caption><p>Pain scores at different time points (point, x&#x000b1;s).</p></caption><table frame="hsides" rules="rows" width="100%"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Group</th><th align="center" valign="top" rowspan="1" colspan="1">Case No. (n)</th><th align="center" valign="top" rowspan="1" colspan="1">Postoperative 2 h</th><th align="center" valign="top" rowspan="1" colspan="1">Postoperative 12 h</th><th align="center" valign="top" rowspan="1" colspan="1">Postoperative 48 h</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Treatment group</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">2.76&#x000b1;0.56</td><td align="center" rowspan="1" colspan="1">2.45&#x000b1;0.29</td><td align="center" rowspan="1" colspan="1">1.71&#x000b1;0.56</td></tr><tr><td align="left" rowspan="1" colspan="1">Control group</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">3.87&#x000b1;0.67</td><td align="center" rowspan="1" colspan="1">2.50&#x000b1;0.31</td><td align="center" rowspan="1" colspan="1">1.81&#x000b1;0.76</td></tr><tr><td align="left" rowspan="1" colspan="1">t</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">7.298</td><td align="center" rowspan="1" colspan="1">0.583</td><td align="center" rowspan="1" colspan="1">0.981</td></tr><tr><td align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x0003c;0.05</td><td align="center" rowspan="1" colspan="1">&#x0003e;0.05</td><td align="center" rowspan="1" colspan="1">&#x0003e;0.05</td></tr></tbody></table></table-wrap><p>In the meantime, the required lidocaine concentrations of the treatment group were 2.64&#x000b1;1.23 &#x003bc;g/ml, 1.14&#x000b1;0.4 &#x003bc;g/ml and 0.93&#x000b1;0.32 &#x003bc;g/ml respectively 2 hour, 12 hour and 48 hour after surgery.</p></sec><sec id="sec2-13"><title>Adverse reactions</title><p>Postoperative adverse reactions, such as nausea and vomiting, dizziness, headache, subcutaneous emphysema and fat liquefaction of incision, occurred similarly in the two groups, which were alleviated by symptomatic treatment (<xref ref-type="table" rid="T5">Table-V</xref>).</p><table-wrap id="T5" position="float"><label>Table-V</label><caption><p>Postoperative adverse reactions (n).</p></caption><table frame="hsides" rules="rows" width="100%"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Group</th><th align="center" valign="top" rowspan="1" colspan="1">Case No. (n)</th><th align="center" valign="top" rowspan="1" colspan="1">Nausea and vomiting</th><th align="center" valign="top" rowspan="1" colspan="1">Dizziness and headache</th><th align="center" valign="top" rowspan="1" colspan="1">Subcutaneous emphysema</th><th align="center" valign="top" rowspan="1" colspan="1">Fat liquefaction of incision</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Treatment group</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Control group</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Uc</td><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1">0.193</td></tr><tr><td align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1">&#x0003e;0.05</td></tr></tbody></table></table-wrap></sec></sec><sec id="sec1-4"><title>DICUSSION</title><p>As a common and frequently-occurring disease, cholelithiasis is now being mainly treated by surgeries among which laparoscopic common bile duct exploration has been widely applied. In this study, all patients successfully completed the surgery, and their surgical time, incision length and intraoperative blood loss were insignificantly different.<xref rid="ref9" ref-type="bibr">9</xref> Although this surgery avoids major traumas and decreases operation steps, patients may suffer from sharp pain because rich nerve endings at the surgical site are stimulated. Meanwhile, they are prone to postoperative adverse reactions in the absence of fulfilling recovery projects, thus posing high requirements for anesthesia and analgesia.<xref rid="ref10" ref-type="bibr">10</xref> Routine anesthetic agents mainly include long-lasting local anaesthetics, opioid antagonists and non-steroidal anti-inflammatory drugs, of which lidocaine, as an amide local anesthetic, immediately exerts effects after being absorbed in the blood or intravenously administered, with its plasma concentration leveling off after 3-4 hour of continuous intravenous infusion.<xref rid="ref11" ref-type="bibr">11</xref> Being consistent with the above analysis, the treatment group herein required 2.64&#x000b1;1.23 &#x003bc;g/ml, 1.14&#x000b1;0.4 &#x003bc;g/ml and 0.93&#x000b1;0.32 &#x003bc;g/ml lidocaine respectively 2 hour, 12 h and 48 h after surgery.</p><p>Postoperative pain not only torments patients physically and psychologically, but also increases the risk of adverse reactions, while postponing recovery also. Hence, it is of great significance to relieve their pain and emotional stress so as to maintain comfortable recovery, to reduce the incidence rate of perioperative cardiovascular adverse reactions, and to allow early ambulation.<xref rid="ref12" ref-type="bibr">12</xref> It has previously been reported that perioperative intravenous injection of lidocaine can enhance the postoperative analgesic effect and accelerate early recovery, and that intraoperative continuous infusion can effectively prevent central hyperalgesia through the nociceptive pathway.<xref rid="ref13" ref-type="bibr">13</xref> In this study, pain score of the treatment group, which was significantly lower than that of the control group at the postoperative 2 hour (P&#x0003c;0.05), was similar to those of the control group at the postoperative 12 hour and 48 hour. With extended time, the pain score significantly decreased (P&#x0003c;0.05). Probably, the pain was milder than that during movement, and normal saline may have local analgesic effect by cooling or diluting intra-articular algogenic substances, leading to similar pain scores of the two groups with elapsed time.<xref rid="ref14" ref-type="bibr">14</xref> Moreover, by preventing the migration and activation of lymphocytes, lidocaine can mitigate local inflammatory response-induced central hyperalgesia and postoperative pain.<xref rid="ref15" ref-type="bibr">15</xref></p><p>Surgeries are bound to induce traumas and gastrointestinal disorders, but lidocaine is able to reduce the dose of opioids and to directly suppress sympathetic plexuses. In addition, it blocks the sodium channel, thereby inhibiting G protein-coupled receptors, spontaneous pulses of injured dorsal root ganglia and peripheral nerves, as well as pain signal transduction.<xref rid="ref16" ref-type="bibr">16</xref> In this study, the treatment group had significantly shorter first anal exhaust time and first defecation time than those of the control group (P&#x0003c;0.05), suggesting that lidocaine was beneficial to the recovery of gastrointestinal function.</p><p>Notably, long-term use of lidocaine may result in adverse reactions. However, nausea and vomiting, bradycardia and fatigue after intravenous infusion of lidocaine (plasma concentration: 5&#x003bc;g/ml) for five days to treat chronic pain disappear 12 hour after drug discontinuance.<xref rid="ref17" ref-type="bibr">17</xref>,<xref rid="ref18" ref-type="bibr">18</xref> The two groups herein had similar adverse reactions such as nausea and vomiting, dizziness, headache, subcutaneous emphysema and fat liquefaction of incision, which were alleviated by symptomatic treatment. The outcomes may be attributed to low plasma lidocaine concentration.<xref rid="ref19" ref-type="bibr">19</xref> Regardless, the plasma concentration, safe dose and administration duration of continuously intravenously infused lidocaine must be further studied.</p><p>In summary, laparoscopic common bile duct exploration is a promising minimally invasive surgery for patients with cholelithiasis. Intravenous infusion of lidocaine can rapidly recover the gastrointestinal function and exert short-term analgesic effects, accompanied by mild adverse reactions as well.</p></sec></body><back><fn-group><fn fn-type="other"><p><bold><italic>Declaration of interest:</italic></bold> There are no conflicts of interest to declare.</p></fn><fn fn-type="supported-by"><p><bold><italic>Source of funding:</italic></bold> There is no source of funding.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelat</surname><given-names>VG</given-names></name><name><surname>Chia</surname><given-names>VJ</given-names></name><name><surname>Low</surname><given-names>J</given-names></name></person-group><article-title>Common bile duct exploration in an elderly Asian population</article-title><source>Int Surg</source><year>2015</year><volume>100</volume><issue>2</issue><fpage>261</fpage><lpage>267</lpage><comment>doi:10.9738/INTSURG-D-13-00168.1</comment><pub-id pub-id-type="pmid">25692428</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersson</surname><given-names>U</given-names></name><name><surname>Johansen</surname><given-names>D</given-names></name><name><surname>Montgomery</surname><given-names>A</given-names></name></person-group><article-title>Laparoscopic transcystic laser lithotripsy for common bile duct stone clearance</article-title><source>Surg Laparosc Endosc Percutan Tech</source><year>2015</year><volume>25</volume><issue>1</issue><fpage>33</fpage><lpage>36</lpage><comment>doi:10.1097/SLE.0b013e31829cec5d</comment><pub-id pub-id-type="pmid">25635672</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>WJ</given-names></name><name><surname>Xu</surname><given-names>GF</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>KL</given-names></name><name><surname>Dong</surname><given-names>ZT</given-names></name><name><surname>Li</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Treatment of gallbladder stone with common bile duct stones in the laparoscopic era</article-title><source>BMC Surg</source><year>2015</year><volume>15</volume><issue>1</issue><fpage>7</fpage><comment>doi:10.1186/1471-2482-15-7</comment><pub-id pub-id-type="pmid">25623774</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Qian</surname><given-names>D</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>Z</given-names></name></person-group><article-title>Primary Closure and Rate of Bile Leak following Laparoscopic Common Bile Duct Exploration via Choledochotomy</article-title><source>Dig Surg</source><year>2015</year><volume>32</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><comment>doi:10.1159/000368326</comment><pub-id pub-id-type="pmid">25613528</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>JG</given-names></name><name><surname>Zhang</surname><given-names>ZT</given-names></name></person-group><article-title>Laparoscopic remnant cholecystectomy and transcystic common bile duct exploration for gallbladder/cystic duct remnant with stones and choledocholithiasis after cholecystectomy</article-title><source>J Laparoendosc Adv Surg Tech A</source><year>2015</year><volume>25</volume><issue>1</issue><fpage>7</fpage><lpage>11</lpage><comment>doi:10.1089/lap.2014.0186</comment><pub-id pub-id-type="pmid">25535723</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x0015e;urlin</surname><given-names>V</given-names></name><name><surname>S&#x00103;ftoiu</surname><given-names>A</given-names></name><name><surname>Dumitrescu</surname><given-names>D</given-names></name></person-group><article-title>Imaging tests for accurate diagnosis of acute biliary pancreatitis</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><issue>44</issue><fpage>16544</fpage><lpage>16549</lpage><comment>doi:10.3748/wjg.v20.i44.16544</comment><pub-id pub-id-type="pmid">25469022</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram</surname><given-names>D</given-names></name><name><surname>Sistla</surname><given-names>SC</given-names></name><name><surname>Karthikeyan</surname><given-names>VS</given-names></name><name><surname>Ali</surname><given-names>SM</given-names></name><name><surname>Badhe</surname><given-names>AS</given-names></name><name><surname>Mahalakshmy</surname><given-names>T</given-names></name></person-group><article-title>Comparison of intravenous and intraperitoneal lignocaine for pain relief following laparoscopic cholecystectomy: a double-blind, randomized, clinical trial</article-title><source>Surg Endosc</source><year>2014</year><volume>28</volume><issue>4</issue><fpage>1291</fpage><lpage>1297</lpage><comment>doi:10.1007/s00464-013-3325-5</comment><pub-id pub-id-type="pmid">24357420</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>MZ</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>TC</given-names></name></person-group><article-title>Excellent postoperative analgesia with the addition of hyaluronidase to lignocaine for subcostal TAP block used in conjunction with systemic analgesia for laparoscopic cholecystectomy</article-title><source>BMJ Case Rep</source><year>2014</year><volume>2</volume><issue>7</issue><comment>doi:10.1136/bcr-2013-202911</comment></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuksek</surname><given-names>YN</given-names></name><name><surname>Akat</surname><given-names>AZ</given-names></name><name><surname>Gozalan</surname><given-names>U</given-names></name><name><surname>Daglar</surname><given-names>G</given-names></name><name><surname>Pala</surname><given-names>Y</given-names></name><name><surname>Canturk</surname><given-names>M</given-names></name><etal/></person-group><article-title>Laparoscopic cholecystectomy under spinal anesthesia</article-title><source>Am J Surg</source><year>2008</year><volume>195</volume><issue>4</issue><fpage>533</fpage><lpage>536</lpage><comment>doi:10.1016/j.amjsurg.2007.05.043</comment><pub-id pub-id-type="pmid">18304510</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzun</surname><given-names>S</given-names></name><name><surname>Erden</surname><given-names>IA</given-names></name><name><surname>Canbay</surname><given-names>O</given-names></name><name><surname>Aypar</surname><given-names>U</given-names></name></person-group><article-title>The effect of intravenous paracetamol for the prevention of rocuronium injection pain</article-title><source>Kaohsiung J Med Sci</source><year>2014</year><volume>30</volume><issue>11</issue><fpage>566</fpage><lpage>569</lpage><comment>doi:10.1016/j.kjms.2014.08.002</comment><pub-id pub-id-type="pmid">25458046</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanos</surname><given-names>SP</given-names></name><name><surname>Galluzzi</surname><given-names>KE</given-names></name></person-group><article-title>Topical therapies in the management of chronic pain</article-title><source>Postgrad Med</source><year>2013</year><volume>125</volume><issue>4 Suppl 1</issue><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">24547601</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>V</given-names></name><name><surname>Hyman</surname><given-names>N</given-names></name><name><surname>Viscomi</surname><given-names>C</given-names></name><name><surname>Osler</surname><given-names>T</given-names></name></person-group><article-title>Implementing a fast-track protocol for patients undergoing bowel resection: not so fast</article-title><source>Am J Surg</source><year>2013</year><volume>206</volume><issue>2</issue><fpage>152</fpage><lpage>158</lpage><comment>doi:10.1016/j.amjsurg.2012.11.019</comment><pub-id pub-id-type="pmid">23759698</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>V</given-names></name><name><surname>Parsons</surname><given-names>S</given-names></name><name><surname>Gallego</surname><given-names>D</given-names></name><name><surname>Huizinga</surname><given-names>J</given-names></name><name><surname>Jimenez</surname><given-names>M</given-names></name></person-group><article-title>Effects of hydrogen sulphide on motility patterns in the rat colon</article-title><source>Br J Pharmacol</source><year>2013</year><volume>169</volume><issue>1</issue><fpage>34</fpage><lpage>50</lpage><comment>doi:10.1111/bph.12100</comment><pub-id pub-id-type="pmid">23297830</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbera</surname><given-names>N</given-names></name><name><surname>Busard&#x000f2;</surname><given-names>FP</given-names></name><name><surname>Indorato</surname><given-names>F</given-names></name><name><surname>Romano</surname><given-names>G</given-names></name></person-group><article-title>The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome</article-title><source>Forensic Sci Int</source><year>2013</year><volume>227</volume><issue>1-3</issue><fpage>74</fpage><lpage>76</lpage><comment>doi:10.1016/j.forsciint.2012.08.041</comment><pub-id pub-id-type="pmid">23000137</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeRossi</surname><given-names>R</given-names></name><name><surname>Maciel</surname><given-names>FB</given-names></name><name><surname>M&#x000f3;dolo</surname><given-names>TJ</given-names></name><name><surname>Pagliosa</surname><given-names>RC</given-names></name></person-group><article-title>Efficacy of concurrent epidural administration of neostigmine and lidocaine for perineal analgesia in geldings</article-title><source>Am J Vet Res</source><year>2012</year><volume>73</volume><issue>9</issue><fpage>1356</fpage><lpage>1362</lpage><comment>doi:10.2460/ajvr.73.9.1356</comment><pub-id pub-id-type="pmid">22924716</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>S</given-names></name><name><surname>Mabe</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><etal/></person-group><article-title>Endoscopic submucosal dissection of oropharyngeal carcinoma by using local lidocaine injection with the patient under conscious sedation</article-title><source>Gastrointest Endosc</source><year>2012</year><volume>75</volume><issue>5</issue><fpage>1108</fpage><lpage>1110</lpage><comment>doi:10.1016/j.gie.2011.05.041</comment><pub-id pub-id-type="pmid">21835402</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ElGeidie</surname><given-names>AA</given-names></name></person-group><article-title>Single-session minimally invasive management of common bile duct stones</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><issue>41</issue><fpage>15144</fpage><lpage>15152</lpage><comment>doi:10.3748/wjg.v20.i41.15144</comment><pub-id pub-id-type="pmid">25386063</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costi</surname><given-names>R</given-names></name><name><surname>Gnocchi</surname><given-names>A</given-names></name><name><surname>Di Mario</surname><given-names>F</given-names></name><name><surname>Sarli</surname><given-names>L</given-names></name></person-group><article-title>Diagnosis and management of choledocholithiasis in the golden age of imaging, endoscopy and laparoscopy</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><issue>37</issue><fpage>13382</fpage><lpage>13401</lpage><comment>doi:10.3748/wjg.v20.i37.13382</comment><pub-id pub-id-type="pmid">25309071</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teitelbaum</surname><given-names>EN</given-names></name><name><surname>Soper</surname><given-names>NJ</given-names></name><name><surname>Santos</surname><given-names>BF</given-names></name><name><surname>Rooney</surname><given-names>DM</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Nagle</surname><given-names>AP</given-names></name><etal/></person-group><article-title>A simulator-based resident curriculum for laparoscopic common bile duct exploration</article-title><source>Surgery</source><year>2014</year><volume>156</volume><issue>4</issue><fpage>880</fpage><lpage>887</lpage><comment>doi:10.1016/j.surg.2014.06.020</comment><pub-id pub-id-type="pmid">25239339</pub-id></element-citation></ref></ref-list><sec id="sec1-5"><title/><sec id="sec2-14"><title>Authors&#x02019; Contributions</title><p><bold>WY</bold> designed the concept and the study.</p><p><bold>WLH</bold> performed the study and prepared the manuscript.</p></sec></sec></back></article>